Alignment Healthcare (NASDAQ:ALHC) Insider Sells $320,451.27 in Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) insider Christopher Joyce sold 18,013 shares of Alignment Healthcare stock in a transaction on Wednesday, April 1st. The stock was sold at an average price of $17.79, for a total value of $320,451.27. Following the sale, the insider owned 305,451 shares in the company, valued at $5,433,973.29. This trade represents a 5.57% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this link.

Alignment Healthcare Price Performance

Shares of NASDAQ:ALHC opened at $18.76 on Friday. Alignment Healthcare, Inc. has a 1 year low of $11.63 and a 1 year high of $23.87. The company has a market capitalization of $3.83 billion, a PE ratio of -1,874.13, a price-to-earnings-growth ratio of 2.74 and a beta of 1.20. The business has a fifty day moving average price of $19.46 and a two-hundred day moving average price of $18.89. The company has a debt-to-equity ratio of 1.80, a current ratio of 1.71 and a quick ratio of 1.71.

Alignment Healthcare (NASDAQ:ALHC) last released its earnings results on Thursday, February 26th. The company reported ($0.05) EPS for the quarter, topping analysts’ consensus estimates of ($0.15) by $0.10. The company had revenue of $1.01 billion for the quarter, compared to analysts’ expectations of $1 billion. Alignment Healthcare had a negative return on equity of 0.49% and a negative net margin of 0.02%.The business’s revenue for the quarter was up 44.4% compared to the same quarter last year. During the same period in the previous year, the business posted ($0.16) EPS. Analysts forecast that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current year.

Hedge Funds Weigh In On Alignment Healthcare

Large investors have recently modified their holdings of the business. Summit Securities Group LLC purchased a new stake in shares of Alignment Healthcare during the 4th quarter valued at approximately $26,000. Parallel Advisors LLC raised its holdings in Alignment Healthcare by 87.7% during the 4th quarter. Parallel Advisors LLC now owns 1,654 shares of the company’s stock valued at $33,000 after acquiring an additional 773 shares during the period. Larson Financial Group LLC bought a new stake in Alignment Healthcare during the 3rd quarter valued at $33,000. First Horizon Corp purchased a new stake in shares of Alignment Healthcare during the fourth quarter worth $39,000. Finally, GAMMA Investing LLC lifted its position in shares of Alignment Healthcare by 83.8% during the fourth quarter. GAMMA Investing LLC now owns 2,165 shares of the company’s stock worth $43,000 after acquiring an additional 987 shares in the last quarter. Hedge funds and other institutional investors own 86.19% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have weighed in on ALHC shares. Wall Street Zen cut shares of Alignment Healthcare from a “buy” rating to a “hold” rating in a research note on Saturday, March 7th. Robert W. Baird set a $28.00 price target on shares of Alignment Healthcare in a research note on Friday, January 30th. JPMorgan Chase & Co. lifted their price target on shares of Alignment Healthcare from $23.00 to $26.00 and gave the stock an “overweight” rating in a report on Thursday, February 5th. TD Cowen upped their price objective on Alignment Healthcare from $18.50 to $25.00 and gave the company a “buy” rating in a research note on Friday, January 16th. Finally, KeyCorp reissued an “overweight” rating and set a $28.00 price objective on shares of Alignment Healthcare in a report on Thursday, January 22nd. One equities research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, three have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $24.56.

About Alignment Healthcare

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.